Ph. 858 586 0500    Toll Free 800 854 7453

Enzymes

PI3KC3 Peptide

$50.00
SKU: 350480
PI3KC3 is the catalytic subunit of the PI3K complex and is involved in the transport of lysosomal enzyme precursors to lysosomes. PI3KC3 associates with regulatory subunit PIK3R4.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Protein Family 
Pathway and Disease 
Carbohydrate Metabolism
Folding
Sorting and Degradation
Signal Transduction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Phosphatidylinositol 3-kinase catalytic subunit 3; PtdIns-3-kinase type 3; PI3-kinase type 3; PI3K type 3; Phosphoinositide-3-kinase class 3; Phosphatidylinositol 3-kinase p100 subunit; PIK3C3
Composition 
C79H141N35O28S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200118 is selected from a sequence within the N-term region of human PI3KC3. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2061.2 g/mol
Unit 
0.1 mg

PERK Peptide

$50.00
SKU: 350479
PERK, a Ser/Thr protein kinase, phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2 (EIF2), leading to its inactivation and to a rapid reduction of translational initiation and repression of global protein synthesis. PERK serves as a critical effector of unfolded protein response (UPR)-induced G1 growth arrest due to the loss of cyclin D1. Defects in PERK are the cause of Wolcott-Rallison syndrome, an early-onset diabetes mellitus.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Protein Family 
Pathway and Disease 
Cell Growth and Death
Metabolic Disorders
Translation
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Eukaryotic translation initiation factor 2-alpha kinase 3; PRKR-like endoplasmic reticulum kinase; Pancreatic eIF2-alpha kinase; HsPEK; EIF2AK3; PEK; PERK
Composition 
C79H141N35O28S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200117 is selected from a sequence within the C-term region of human PERK. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2061.2 g/mol
Unit 
0.1 mg

PDK4 Peptide

$50.00
SKU: 350478
PDK4 inhibits the mitochondrial pyruvate dehydrogenase complex by phosphorylation of the E1 alpha subunit, thus contributing to the regulation of glucose metabolism.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Protein Family 
Pathway and Disease 
Carbohydrate Metabolism
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Pyruvate dehydrogenase lipoamide kinase isozyme 4; Pyruvate dehydrogenase kinase isoform 4; PDK4
Composition 
C71H123N21O22S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200116 is selected from a sequence within the C-term region of human PDK4. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1654.9 g/mol
Unit 
0.1 mg

LRRK2 Peptide

$50.00
SKU: 350477
LRRK2 is involved in the phosphorylation of proteins central to Parkinson disease. Defects in LRRK2 are the cause of Parkinson disease 8 (PARK8).
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Protein Family 
Pathway and Disease 
Neurodegenerative Disorders
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Leucine-rich repeat serine/threonine protein kinase 2; Dardarin; PARK8
Composition 
C94H156N30O28S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200115 is selected from a sequence within the C-term region of human LRRK2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2186.5 g/mol
Unit 
0.1 mg

OAS1 Peptide

$50.00
SKU: 350476
OAS1 is involved in mediating resistance to virus infection, control of cell growth, differentiation, and apoptosis. OAS1 binds double-stranded RNA and polymerizes ATP into PPP(A2'P5'A)N oligomers, which activate the latent Rnase L to cleaves single-stranded RNAs.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Protein Family 
Pathway and Disease 
Cell Growth and Death
Development and Behavior
Immune System
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
2'-5'-oligoadenylate synthetase 1; 2-5' oligo(A) synthetase 1; 2-5A synthetase 1; p46/p42 OAS; E18/E16; OAS1; OIAS
Composition 
C89H139N19O29S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200114 is selected from a sequence within the N-term region of human OAS1. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1971.2 g/mol
Unit 
0.1 mg

HGFR Peptide

$50.00
SKU: 350475
HGFR (MET), a tyrosine protein kinase, is the receptor for the hepatocyte growth factor and scater factor. Activation of HGFR after rearrangement with the TPR gene produces an oncogenic protein c-MET. Defects in HGFR/MET are a cause of hepatocellular carcinoma and renal carcinoma.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Cell Communication
Development and Behavior
Infectious Diseases
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Hepatocyte growth factor receptor; HGF receptor; Scatter factor receptor; SF receptor; HGF/SF receptor; Met proto-oncogene tyrosine kinase; c-Met
Composition 
C83H139N23O27S3
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200113 is selected from a sequence within the N-term region of human HGFR. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1987.3 g/mol
Unit 
0.1 mg

DDR1 Peptide

$50.00
SKU: 350474
DDR1 is involved in cell-cell interactions and recognition.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Communication
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Epithelial discoidin domain-containing receptor 1; Epithelial discoidin domain receptor 1; Tyrosine kinase DDR; Discoidin receptor tyrosine kinase; Tyrosine-protein kinase CAK; Cell adhesion kinase; TRK E; Protein-tyrosine kinase RTK 6; CD167a antigen; HGK2; DDR1; EDDR1; NEP; NTRK4; PTK3A; RTK6; TRKE
Composition 
C84H137N25O30S2
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200112 is selected from a sequence within the N-term region of human DDR1. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2041.2 g/mol
Unit 
0.1 mg

KIT Peptide

$50.00
SKU: 350473
KIT is the receptor for stem cell factor (mast cell growth factor). KIT has a tyrosine protein kinase activity. Defects in KIT are a cause of piebaldism (lack of melanocytes), gastrointestinal stromal tumors and testicular tumors.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Endocrine System
Immune System
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Mast/stem cell growth factor receptor; SCFR; Proto-oncogene tyrosine-protein kinase Kit; c-kit; CD117 antigen; KIT
Composition 
C80H128N24O29S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200111 is selected from a sequence within the C-term region of human KIT. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1922.1 g/mol
Unit 
0.1 mg

INSR Peptide

$50.00
SKU: 350472
INSR binds insulin and has a tyrosine protein kinase activity. The short isoform has a higher affinity for insulin. The receptor mediates the metabolic functions of insulin. The receptor binding to insulin stimulates association of the receptor with downstream mediators including IRS1 and phosphatidylinositol 3'-kinase (PI3K). Defects in INSR are the cause of insulin resistance.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Communication
Endocrine System
Metabolic Disorders
Neurodegenerative Disorders
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Insulin receptor; CD220 antigen; IR; INSR
Composition 
C87H138N24O25S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200110 is selected from a sequence within the N-term region of human INSR. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1952.2 g/mol
Unit 
0.1 mg

IGF1R Peptide

$50.00
SKU: 350471
IGF1R binds insulin-like growth factor 1 (IGF1) with high affinity and IGF2 with low affinity. The receptor has a tyrosine protein kinase activity necessary for the activation of the IGF1-stimulated downstream signaling cascade.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Cell Communication
Nervous and Sensory Systems
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Insulin-like growth factor I receptor; CD221 antigen; IGF-I receptor; IGF1R
Composition 
C72H125N25O24S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200109 is selected from a sequence within the C-term region of human IGF1R. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1757 g/mol
Unit 
0.1 mg

Pages

Subscribe to RSS - Enzymes